Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Open-label Phase 2 Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway

NCT03652493 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT03652493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03652493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Open-label Phase 2 Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway
Lead sponsor
Centre Francois Baclesse
Phase
Phase 2
Overall status
Completed
Start date
September 10, 2018
Completion date
May 21, 2021
Enrollment
16 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer, metastasis